Radio and PodcastRadio and PodcastLive Radio & Podcasts
mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review artwork
Science & Medicine

mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review

Oncotarget by Oncotarget Podcast

Feb 27, 202600:08:38Science & Medicine

The rapid development and global deployment of mRNA vaccines for COVID-19 represented a landmark achievement in public health. However, the novel mechanism of these “genetic vaccines”—technically pro-drug gene therapies...

About This Episode

mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review is an episode from Oncotarget by Oncotarget Podcast. The rapid development and global deployment of mRNA vaccines for COVID-19 represented a landmark achievement in public healt...

Podcast

This episode belongs to Oncotarget.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Feb 27, 2026, 00:08:38 long, audio available.

Questions About This Episode

What is mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review about?

The rapid development and global deployment of mRNA vaccines for COVID-19 represented a landmark achievement in public health. However, the novel mechanism of these “genetic vaccines”—technically pro-drug gene therapies encased in lipid nanoparticles—has prompted ongoing scientific inquiry into their potential long-term effects. A comprehensive case report and review, titled “Exploring the potential link between mRNA COVID-19 vaccinations and cancer: A case report with a review of haematopoietic malignancies with insights into pathogenic mechanisms” published in Oncotarget by an international team of researchers investigates a consequential scientific question: whether there could be a link between mRNA COVID-19 vaccines and the development of haematopoietic cancers. Led by first author Patrizia Gentilini, along with corresponding author Panagis Polykretis of the “Allineare Sanità e Salute” Foundation and Independent Medical Scientific Commission (CMSi), Milano, the paper presents a detailed case study alongside a systematic review of existing literature. It does not claim to have proven a causal link, but instead argues that the convergence of clinical observations and proposed biological mechanisms warrants deeper, more urgent investigation. Full blog - Paper DOI - Correspondence to - Panagis Polykretis - panagis.polykretis@gmail.com Abstract video - Sign up for free Altmetric alerts about this article -

Where can I listen to mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review?

You can listen to mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review from?

mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review is an episode from Oncotarget by Oncotarget Podcast.

How long is this episode?

This episode is 00:08:38 long.

When was this episode published?

This episode was published on Feb 27, 2026.

Can I save mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from Oncotarget?

Yes. This page shows related episodes from Oncotarget when more episodes are available from the podcast feed.

Quick Answers About This Episode

Where can I listen to mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review?

You can listen to mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review on this page when the episode audio is available from the podcast feed.

Which podcast is this episode from?

mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review is from Oncotarget by Oncotarget Podcast.

What are the episode details?

Published Feb 27, 2026 and 00:08:38 long